Why the study?
Acute recurrent purulent pericarditis is an uncommon pericardium infection that can be life-threatening due to pus production leading to cardiac tamponade.
Does intrapericardial fibrinolytic administration improve clinical outcomes in a patient with acute recurrent purulent pericarditis and impending cardiac tamponade?
Does intrapericardial fibrinolytic administration improve clinical outcomes in a patient with acute recurrent purulent pericarditis and impending cardiac tamponade?
Intrapericardial fibrinolytic administration following pericardiocentesis may be an effective therapeutic option for managing acute recurrent purulent pericarditis with impending cardiac tamponade.
Rare recurrent purulent pericarditis with tamponade requires urgent pericardiocentesis; case reports leave optimal management open for prospective study.
Introduction: Acute recurrent purulent pericarditis is an uncommon pericardium infection that can be life-threatening due to pus production, leading to cardiac tamponade. Case presentation: We report a 36-year-old man referring to our hospital with impending cardiac tamponade who needed urgent pericardiocentesis. The patient's complaints were worsening dyspnea and palpitations in the last two days. The patient had been hospitalized for the same complaint and had pericardiocentesis due to cardiac tamponade approximately three weeks earlier. Physical exam, ECG, and CXR suggest impending cardiac tamponade. Echocardiography indicated massive right and left pericardial effusion and right atrial collapse. The Covid-19 screening test was positive; however, RT-PCR revealed a negative result. The patient was diagnosed with recurrent acute purulent pericarditis with impending cardiac tamponade requiring urgent pericardiocentesis. After the procedure, 1.5 million units of intrapericardial fibrinolytic were administered to patients. His improved hemodynamic and clinical symptoms indicate a successful procedure. Conclusion: This case highlights the challenges of managing an acute recurrent purulent pericarditis patient due to Staphylococcus A. infection in the current pandemic era, including distinguishing it from other contagious diseases due to nonspecific dyspnea, limited therapeutic options, and the effectiveness of intrapericardial fibrinolytic in improving the overall patient conditions, and reducing the mortality rate.
No takes yet. Share an insight, caveat, or question.
Pratama et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: